Genetically predicted glucose-dependent insulinotropic polypeptide (GIP) levels and cardiovascular disease risk are driven by distinct causal variants in the GIPR region (2021)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.2337/figshare.15175518.v2
Publication URI: http://dx.doi.org/10.2337/figshare.15175518.v2
Type: Other